Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges in operationalising clinical trials in India during the COVID-19 pandemic
Abhinav Bassi, Sumaiya Arfin, Rohina Joshi, et al.
The Lancet Global Health (2021) Vol. 10, Iss. 3, pp. e317-e319
Open Access | Times Cited: 19

Showing 19 citing articles:

National ICU Registries as Enablers of Clinical Research and Quality Improvement
Jorge I. Salluh, Amanda Quintairos, Dave A. Dongelmans, et al.
Critical Care Medicine (2023) Vol. 52, Iss. 1, pp. 125-135
Closed Access | Times Cited: 19
Challenges and solutions in clinical research during the COVID‐19 pandemic: A narrative review
Mahin Nomali, Neda Mehrdad, Mohammad Heidari, et al.
Health Science Reports (2023) Vol. 6, Iss. 8
Open Access | Times Cited: 18
The target trial framework in global health research: barriers and opportunities
Ali Al‐kassab‐Córdova, Esteban A. Alarcón‐Braga, Camila Olarte Parra, et al.
Journal of Global Health (2025) Vol. 15
Open Access
COVID-19 human challenge trials and randomized controlled trials: lessons for the next pandemic
Charles Weijer
Research Ethics (2024) Vol. 20, Iss. 4, pp. 636-649
Open Access | Times Cited: 4
Knowledge and Attitude towards Clinical Trials among General Population of Northern Saudi Arabia during COVID-19 Era: A Cross-Sectional Study
Mohamed Abouelkheir, Ahmed E. Taha, Ashokkumar Thirunavukkarasu, et al.
Healthcare (2023) Vol. 11, Iss. 5, pp. 680-680
Open Access | Times Cited: 4
Protocol implementation during the COVID-19 pandemic: experiences from a randomized trial of stress ulcer prophylaxis
Brittany B. Dennis, Adam M. Deane, François Lauzier, et al.
BMC Medical Research Methodology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Cancer Trials Ecosystem in India—Ready for Prime Time?
Arun K. Mankan, Abhishek Shankar, Sewanti Limaye, et al.
JCO Global Oncology (2024), Iss. 10
Open Access | Times Cited: 1
LEDoxy-SL: A Placebo-Controlled, Double-Blind, Randomized, 24-Month Trial of Six Weeks of Daily Doxycycline Plus Hygiene-Based Essential Care for Reducing Progression of Filarial Lymphedema in Sri Lanka
Thishan C. Yahathugoda, Nirmitha Lalindi De Silva, J. Eugene Ruben, et al.
American Journal of Tropical Medicine and Hygiene (2024) Vol. 111, Iss. 4_Suppl, pp. 52-65
Closed Access | Times Cited: 1
Clinical Trials: The Role of Regulatory Agencies, Pharmacovigilance Laws, Guidelines, Risk Management, Patenting, and Publicizing Results
Venkataramana Kandi, Sabitha Vadakedath, Purna Singh Addanki, et al.
Borneo Journal of Pharmacy (2023) Vol. 6, Iss. 1, pp. 93-109
Open Access | Times Cited: 3
Early phase clinical trials in India: Need & scope
Nilima Arun Kshirsagar, Monika Pahuja, N S Chatterjee, et al.
The Indian Journal of Medical Research (2023) Vol. 158, Iss. 1, pp. 17-17
Open Access | Times Cited: 3
A Pilot Feasibility Randomized Controlled Trial of Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit: The Lessening Organ Dysfunction with Vitamin C-India (LOVIT-India) Trial
Bharath Kumar Tirupakuzhi Vijayaraghavan, Ramesh Venkataraman, Yamunadevi Ramanathan, et al.
Indian Journal of Critical Care Medicine (2023) Vol. 27, Iss. 12, pp. 910-916
Open Access | Times Cited: 3
Emerging drugs for the treatment of acne: a review of phase 2 & 3 trials
Siddharth Bhatt, Rohit Kothari, Durga Madhab Tripathy, et al.
Expert Opinion on Emerging Drugs (2022) Vol. 27, Iss. 3, pp. 241-261
Closed Access | Times Cited: 4
Complexity of clinical trial operationalisation in India
Santhosh Shivabasappa, Akila Srinivasan
The Lancet Global Health (2022) Vol. 10, Iss. 7, pp. e953-e953
Open Access | Times Cited: 3
N-of-1 behavioural medicine: Revolutionizing health promotion in public health through personalized intervention
Sudip Bhattacharya, Amarjeet Singh, Suneela Garg, et al.
Medical Journal Armed Forces India (2024)
Closed Access
Views from Multinational Pharmaceutical Companies on Allocation of Clinical Trials in Saudi Arabia—Qualitative Study
Nouf M. Aloudah, Ahmed M. Shaman
Pharmacy (2024) Vol. 12, Iss. 6, pp. 167-167
Open Access
Evaluation of satisfaction and reasons for participation in a Covid-19 vaccine clinical trial: A single-centre, observational study
Palvi Kudyar, Dhruve Soni, Nithya Gogtay
The National Medical Journal of India (2023) Vol. 35, pp. 214-218
Open Access | Times Cited: 1
Pandemics move faster than funders

The Lancet (2023) Vol. 402, Iss. 10399, pp. 367-367
Closed Access | Times Cited: 1
Challenges and Opportunities for Smokeless Tobacco Cessation During Covid 19: learnings from a Feasibility trial in India
S. K. Saxena
Clinical Research and Clinical Trials (2023) Vol. 7, Iss. 4, pp. 01-04
Open Access
Birth of a New Journal in Anesthesiology
Kirti N Saxena, Sukhyanti Kerai
Journal of Indian College of Anaesthesiologists (2022) Vol. 1, Iss. 1, pp. 1-2
Closed Access
Page 1

Scroll to top